Figure 2.
HPCLSKcell lines can repopulate the hematopoietic system. (A) Experimental scheme: Ly5.1+-recipient mice were lethally irradiated (10 Gy) 24 hours prior to IV injection of 1 × 107 Ly5.2+ BM (positive control), BM-HPC5, or HPCLSK cells. Forty days later, some mice of the BM and HPCLSK-injected group were euthanized, and hematopoietic organs were analyzed. The remaining injected mice were analyzed for their long-term survival. (B) Survival of BM- (n = 7), BM-HPC5- (n = 8), and HPCLSKs- (n = 10) injected mice compared with radiation control (n = 9), log-rank (Mantel-Cox) test. ***P <.0001. (C) WBCs and red blood cells in peripheral blood of BM- and HPCLSK-injected recipients were compared 40 days after treatment. Data are presented as mean ± standard error of the mean (SEM; *P <.01, Student t test or Mann-Whitney test for platelets) in 6 to 12 mice per group. (D) Comparison of Ly5.2+ BM vs HPCLSK cells’ engraftment in the blood, BM, spleen, and thymus of lethally irradiated Ly5.1+ mice after 40 days. Data are presented as mean ± SD, n ≥ 4. (E) Spleen weights of mice 40 days after lethal irradiation and BM or HPCLSK injection. Data represent mean ± SD, n ≥ 5. (F) Composition of the engrafted Ly5.2+ HPCLSK cells in blood, BM, and thymus after 40 days. ST-HSC, MPP (Lin−, Sca-1+, c-Kit+, CD150−, CD48+), LSKs (Lin−, Sca-1+, c-Kit+), MCP (myeloid committed progenitor, Lin−, IL-7R−, Sca-1−, c-Kit+), GMP (granulocyte-monocyte progenitor, Lin−, IL-7R−, Sca-1−, c-Kit+, CD16/32+, CD34+), CMP (common myeloid progenitor, Lin−, IL-7R−, Sca-1−, c-Kit+, CD16/32−, CD34+), MEP (megakaryocyte-erythrocyte progenitor, Lin−, IL-7R−, Sca-1−, c-Kit+, CD16/32−, CD34−), CLP (common lymphoid progenitor, Lin−, IL7-R+, c-Kitmid, Sca-1mid); and in vivo differentiated populations: erythroblast (CD71/CD44+), granulocyte (Gr-1+), monocyte (CD11b+), eosinophil/neutrophil (Gr-1/CD11b+), T cell (CD4 or CD8+), and B cell (B220+) are depicted as fold change compared with BM-injected mice. n = 6 to 12 per group, *P <.05; **P <.01; ***P <.001 by Student t test. Ctrl, control; inj., injected; ns, not significant; rad, radiation; RBC, red blood cell.

HPCLSKcell lines can repopulate the hematopoietic system. (A) Experimental scheme: Ly5.1+-recipient mice were lethally irradiated (10 Gy) 24 hours prior to IV injection of 1 × 107 Ly5.2+ BM (positive control), BM-HPC5, or HPCLSK cells. Forty days later, some mice of the BM and HPCLSK-injected group were euthanized, and hematopoietic organs were analyzed. The remaining injected mice were analyzed for their long-term survival. (B) Survival of BM- (n = 7), BM-HPC5- (n = 8), and HPCLSKs- (n = 10) injected mice compared with radiation control (n = 9), log-rank (Mantel-Cox) test. ***P <.0001. (C) WBCs and red blood cells in peripheral blood of BM- and HPCLSK-injected recipients were compared 40 days after treatment. Data are presented as mean ± standard error of the mean (SEM; *P <.01, Student t test or Mann-Whitney test for platelets) in 6 to 12 mice per group. (D) Comparison of Ly5.2+ BM vs HPCLSK cells’ engraftment in the blood, BM, spleen, and thymus of lethally irradiated Ly5.1+ mice after 40 days. Data are presented as mean ± SD, n ≥ 4. (E) Spleen weights of mice 40 days after lethal irradiation and BM or HPCLSK injection. Data represent mean ± SD, n ≥ 5. (F) Composition of the engrafted Ly5.2+ HPCLSK cells in blood, BM, and thymus after 40 days. ST-HSC, MPP (Lin, Sca-1+, c-Kit+, CD150, CD48+), LSKs (Lin, Sca-1+, c-Kit+), MCP (myeloid committed progenitor, Lin, IL-7R, Sca-1, c-Kit+), GMP (granulocyte-monocyte progenitor, Lin, IL-7R, Sca-1, c-Kit+, CD16/32+, CD34+), CMP (common myeloid progenitor, Lin, IL-7R, Sca-1, c-Kit+, CD16/32, CD34+), MEP (megakaryocyte-erythrocyte progenitor, Lin, IL-7R, Sca-1, c-Kit+, CD16/32, CD34), CLP (common lymphoid progenitor, Lin, IL7-R+, c-Kitmid, Sca-1mid); and in vivo differentiated populations: erythroblast (CD71/CD44+), granulocyte (Gr-1+), monocyte (CD11b+), eosinophil/neutrophil (Gr-1/CD11b+), T cell (CD4 or CD8+), and B cell (B220+) are depicted as fold change compared with BM-injected mice. n = 6 to 12 per group, *P <.05; **P <.01; ***P <.001 by Student t test. Ctrl, control; inj., injected; ns, not significant; rad, radiation; RBC, red blood cell.

Close Modal

or Create an Account

Close Modal
Close Modal